Injectable tissue-engineered bone repair of a rat calvarial defect

Scott J. Stephan, Sunil S. Tholpady, Brian Gross, Caren E. Petrie-Aronin, Edward A. Botchway, Lakshmi S. Nair, Roy C. Ogle, Stephen S. Park

Research output: Contribution to journalArticle

84 Citations (Scopus)

Abstract

Objectives/Hypothesis: Advances in bone repair have focused on the minimally-invasive delivery of tissue-engineered bone (TEB). A promising injectable biopolymer of chitosan and inorganic phosphates was seeded with mesenchymal stem cells (MSCs) and a bone growth factor (BMP-2), and evaluated in a rat calvarial critical size defect (CSD). Green fluorescent protein (GFP)-labeled MSCs are used to evaluate patterns of cell viability and proliferation. Study Design: Prospective, controlled trial in an animal model. Methods: In 30 male rats, 8-mm calvarial CSDs were created, and divided into five groups of six animals each. In the experimental groups, the defects were injected with either chitosan gel, gel loaded with MSCs (0.3 x 106 cells/defect), gel loaded with BMP-2 (2 lg/defect), or gel loaded with both MSC and BMP-2. In the control group, the defect was left untreated. At 4 weeks, in vivo microcomputed tomography (micro-CT) analysis was performed. At 8 weeks, calvarial specimens were examined by micro-CT, histology, and immunohistochemistry. Results: New areas of bone growth were seen in the defects of all treated animals. Micro-CT analysis revealed a significant (P <.001) time-dependent increase in the regeneration of bone volume and bone area in defects treated with gel/MSC/BMP-2 as compared to all other groups. Histological analysis confirmed this difference. GFP-labeled TEB was detected within the areas of new bone, indicating cell viability and contribution to new bone growth by the injected MSC. Conclusions: This study demonstrates that an injectable form of TEB using a chitosan gel, MSC, and BMP-2 can enhance bone formation in a rat calvarial CSD.

Original languageEnglish (US)
Pages (from-to)895-901
Number of pages7
JournalLaryngoscope
Volume120
Issue number5
DOIs
StatePublished - May 2010
Externally publishedYes

Fingerprint

Mesenchymal Stromal Cells
Bone and Bones
Gels
Injections
Bone Development
Chitosan
X-Ray Microtomography
Green Fluorescent Proteins
Cell Survival
Biopolymers
Osteogenesis
Regeneration
Intercellular Signaling Peptides and Proteins
Histology
Animal Models
Immunohistochemistry
Phosphates
Cell Proliferation
Prospective Studies
Control Groups

Keywords

  • Bone morphogenetic protein
  • Bone regeneration
  • Chitosan
  • Cranial defect
  • Mesenchymal stem cell

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Stephan, S. J., Tholpady, S. S., Gross, B., Petrie-Aronin, C. E., Botchway, E. A., Nair, L. S., ... Park, S. S. (2010). Injectable tissue-engineered bone repair of a rat calvarial defect. Laryngoscope, 120(5), 895-901. https://doi.org/10.1002/lary.20624

Injectable tissue-engineered bone repair of a rat calvarial defect. / Stephan, Scott J.; Tholpady, Sunil S.; Gross, Brian; Petrie-Aronin, Caren E.; Botchway, Edward A.; Nair, Lakshmi S.; Ogle, Roy C.; Park, Stephen S.

In: Laryngoscope, Vol. 120, No. 5, 05.2010, p. 895-901.

Research output: Contribution to journalArticle

Stephan, SJ, Tholpady, SS, Gross, B, Petrie-Aronin, CE, Botchway, EA, Nair, LS, Ogle, RC & Park, SS 2010, 'Injectable tissue-engineered bone repair of a rat calvarial defect', Laryngoscope, vol. 120, no. 5, pp. 895-901. https://doi.org/10.1002/lary.20624
Stephan SJ, Tholpady SS, Gross B, Petrie-Aronin CE, Botchway EA, Nair LS et al. Injectable tissue-engineered bone repair of a rat calvarial defect. Laryngoscope. 2010 May;120(5):895-901. https://doi.org/10.1002/lary.20624
Stephan, Scott J. ; Tholpady, Sunil S. ; Gross, Brian ; Petrie-Aronin, Caren E. ; Botchway, Edward A. ; Nair, Lakshmi S. ; Ogle, Roy C. ; Park, Stephen S. / Injectable tissue-engineered bone repair of a rat calvarial defect. In: Laryngoscope. 2010 ; Vol. 120, No. 5. pp. 895-901.
@article{d79a5afe3b874537a98768f1f5fc0cd8,
title = "Injectable tissue-engineered bone repair of a rat calvarial defect",
abstract = "Objectives/Hypothesis: Advances in bone repair have focused on the minimally-invasive delivery of tissue-engineered bone (TEB). A promising injectable biopolymer of chitosan and inorganic phosphates was seeded with mesenchymal stem cells (MSCs) and a bone growth factor (BMP-2), and evaluated in a rat calvarial critical size defect (CSD). Green fluorescent protein (GFP)-labeled MSCs are used to evaluate patterns of cell viability and proliferation. Study Design: Prospective, controlled trial in an animal model. Methods: In 30 male rats, 8-mm calvarial CSDs were created, and divided into five groups of six animals each. In the experimental groups, the defects were injected with either chitosan gel, gel loaded with MSCs (0.3 x 106 cells/defect), gel loaded with BMP-2 (2 lg/defect), or gel loaded with both MSC and BMP-2. In the control group, the defect was left untreated. At 4 weeks, in vivo microcomputed tomography (micro-CT) analysis was performed. At 8 weeks, calvarial specimens were examined by micro-CT, histology, and immunohistochemistry. Results: New areas of bone growth were seen in the defects of all treated animals. Micro-CT analysis revealed a significant (P <.001) time-dependent increase in the regeneration of bone volume and bone area in defects treated with gel/MSC/BMP-2 as compared to all other groups. Histological analysis confirmed this difference. GFP-labeled TEB was detected within the areas of new bone, indicating cell viability and contribution to new bone growth by the injected MSC. Conclusions: This study demonstrates that an injectable form of TEB using a chitosan gel, MSC, and BMP-2 can enhance bone formation in a rat calvarial CSD.",
keywords = "Bone morphogenetic protein, Bone regeneration, Chitosan, Cranial defect, Mesenchymal stem cell",
author = "Stephan, {Scott J.} and Tholpady, {Sunil S.} and Brian Gross and Petrie-Aronin, {Caren E.} and Botchway, {Edward A.} and Nair, {Lakshmi S.} and Ogle, {Roy C.} and Park, {Stephen S.}",
year = "2010",
month = "5",
doi = "10.1002/lary.20624",
language = "English (US)",
volume = "120",
pages = "895--901",
journal = "Laryngoscope",
issn = "0023-852X",
publisher = "John Wiley and Sons Inc.",
number = "5",

}

TY - JOUR

T1 - Injectable tissue-engineered bone repair of a rat calvarial defect

AU - Stephan, Scott J.

AU - Tholpady, Sunil S.

AU - Gross, Brian

AU - Petrie-Aronin, Caren E.

AU - Botchway, Edward A.

AU - Nair, Lakshmi S.

AU - Ogle, Roy C.

AU - Park, Stephen S.

PY - 2010/5

Y1 - 2010/5

N2 - Objectives/Hypothesis: Advances in bone repair have focused on the minimally-invasive delivery of tissue-engineered bone (TEB). A promising injectable biopolymer of chitosan and inorganic phosphates was seeded with mesenchymal stem cells (MSCs) and a bone growth factor (BMP-2), and evaluated in a rat calvarial critical size defect (CSD). Green fluorescent protein (GFP)-labeled MSCs are used to evaluate patterns of cell viability and proliferation. Study Design: Prospective, controlled trial in an animal model. Methods: In 30 male rats, 8-mm calvarial CSDs were created, and divided into five groups of six animals each. In the experimental groups, the defects were injected with either chitosan gel, gel loaded with MSCs (0.3 x 106 cells/defect), gel loaded with BMP-2 (2 lg/defect), or gel loaded with both MSC and BMP-2. In the control group, the defect was left untreated. At 4 weeks, in vivo microcomputed tomography (micro-CT) analysis was performed. At 8 weeks, calvarial specimens were examined by micro-CT, histology, and immunohistochemistry. Results: New areas of bone growth were seen in the defects of all treated animals. Micro-CT analysis revealed a significant (P <.001) time-dependent increase in the regeneration of bone volume and bone area in defects treated with gel/MSC/BMP-2 as compared to all other groups. Histological analysis confirmed this difference. GFP-labeled TEB was detected within the areas of new bone, indicating cell viability and contribution to new bone growth by the injected MSC. Conclusions: This study demonstrates that an injectable form of TEB using a chitosan gel, MSC, and BMP-2 can enhance bone formation in a rat calvarial CSD.

AB - Objectives/Hypothesis: Advances in bone repair have focused on the minimally-invasive delivery of tissue-engineered bone (TEB). A promising injectable biopolymer of chitosan and inorganic phosphates was seeded with mesenchymal stem cells (MSCs) and a bone growth factor (BMP-2), and evaluated in a rat calvarial critical size defect (CSD). Green fluorescent protein (GFP)-labeled MSCs are used to evaluate patterns of cell viability and proliferation. Study Design: Prospective, controlled trial in an animal model. Methods: In 30 male rats, 8-mm calvarial CSDs were created, and divided into five groups of six animals each. In the experimental groups, the defects were injected with either chitosan gel, gel loaded with MSCs (0.3 x 106 cells/defect), gel loaded with BMP-2 (2 lg/defect), or gel loaded with both MSC and BMP-2. In the control group, the defect was left untreated. At 4 weeks, in vivo microcomputed tomography (micro-CT) analysis was performed. At 8 weeks, calvarial specimens were examined by micro-CT, histology, and immunohistochemistry. Results: New areas of bone growth were seen in the defects of all treated animals. Micro-CT analysis revealed a significant (P <.001) time-dependent increase in the regeneration of bone volume and bone area in defects treated with gel/MSC/BMP-2 as compared to all other groups. Histological analysis confirmed this difference. GFP-labeled TEB was detected within the areas of new bone, indicating cell viability and contribution to new bone growth by the injected MSC. Conclusions: This study demonstrates that an injectable form of TEB using a chitosan gel, MSC, and BMP-2 can enhance bone formation in a rat calvarial CSD.

KW - Bone morphogenetic protein

KW - Bone regeneration

KW - Chitosan

KW - Cranial defect

KW - Mesenchymal stem cell

UR - http://www.scopus.com/inward/record.url?scp=77951708684&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951708684&partnerID=8YFLogxK

U2 - 10.1002/lary.20624

DO - 10.1002/lary.20624

M3 - Article

C2 - 20422682

AN - SCOPUS:77951708684

VL - 120

SP - 895

EP - 901

JO - Laryngoscope

JF - Laryngoscope

SN - 0023-852X

IS - 5

ER -